Miller CL - Search Results

1

Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges.

Miller CL, Tyndall M, Spittal P, Li K, Palepu A, Schechter MT. Miller CL, et al. J Urban Health. 2002 Jun;79(2):257-65. doi: 10.1093/jurban/79.2.257. J Urban Health. 2002. PMID: 12023501 Free PMC article.

2

HIV incidence and associated risk factors among young injection drug users.

Miller CL, Tyndall M, Spittal P, Li K, LaLiberte N, Schechter MT. Miller CL, et al. AIDS. 2002 Feb 15;16(3):491-3. doi: 10.1097/00002030-200202150-00025. AIDS. 2002. PMID: 11834965 No abstract available.

3

Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs.

Miller CL, Spittal PM, LaLiberte N, Li K, Tyndall MW, O'Shaughnessy MV, Schechter MT. Miller CL, et al. J Acquir Immune Defic Syndr. 2002 Jul 1;30(3):335-41. doi: 10.1097/00126334-200207010-00010. J Acquir Immune Defic Syndr. 2002. PMID: 12131571

4

Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users.

Miller CL, Johnston C, Spittal PM, Li K, Laliberté N, Montaner JS, Schechter MT. Miller CL, et al. Hepatology. 2002 Sep;36(3):737-42. doi: 10.1053/jhep.2002.35065. Hepatology. 2002. PMID: 12198668

5

The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users.

Miller CL, Wood E, Spittal PM, Li K, Frankish JC, Braitstein P, Montaner JS, Schechter MT. Miller CL, et al. J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):743-9. doi: 10.1097/00126334-200406010-00012. J Acquir Immune Defic Syndr. 2004. PMID: 15167294

6

Inability to access addiction treatment and risk of HIV infection among injection drug users.

Wood E, Spittal P, Li K, Kerr T, Miller CL, Hogg RS, Montaner JS, Schechter MT. Wood E, et al. Among authors: miller cl. J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):750-4. doi: 10.1097/00126334-200406010-00013. J Acquir Immune Defic Syndr. 2004. PMID: 15167295

7

Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users.

Wood E, Li K, Miller CL, Hogg RS, Montaner JS, Schechter MT, Kerr T. Wood E, et al. Among authors: miller cl. Int J Epidemiol. 2005 Feb;34(1):152-8. doi: 10.1093/ije/dyh357. Epub 2004 Nov 23. Int J Epidemiol. 2005. PMID: 15561747

8

HIV and hepatitis C outbreaks among high-risk youth in Vancouver demands a public health response.

Miller CL, Spittal PM, Frankish JC, Li K, Schechter MT, Wood E. Miller CL, et al. Can J Public Health. 2005 Mar-Apr;96(2):107-8. doi: 10.1007/BF03403671. Can J Public Health. 2005. PMID: 15850028 Free PMC article.

9

Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies.

Miller CL, Kerr T, Frankish JC, Spittal PM, Li K, Schechter MT, Wood E. Miller CL, et al. Subst Use Misuse. 2006;41(2):199-210. doi: 10.1080/10826080500391795. Subst Use Misuse. 2006. PMID: 16393742

10

Surviving the sex trade: a comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs.

Spittal PM, Bruneau J, Craib KJ, Miller C, Lamothe F, Weber AE, Li K, Tyndall MW, O'Shaughnessy MV, Schechter MT. Spittal PM, et al. AIDS Care. 2003 Apr;15(2):187-95. doi: 10.1080/0954012031000068335. AIDS Care. 2003. PMID: 12856340

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

555 results

Search Page

Filters